Results 121 to 130 of about 393,600 (259)

Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease

BMC Research Notes, 2020
Objective Few data are available on the association between SARS-CoV-2 and secondary bacterial infections. Such an association was described for flu and invasive meningococcal disease (IMD).
M. Taha, A. Deghmane
semanticscholar   +1 more source

Invasive Meningococcal Disease in Adolescents and Young Adults [PDF]

JAMA, 2001
Incidence of invasive meningococcal disease has increased recently in persons aged 15 through 24 years.To characterize meningococcal infection in adolescents and young adults in Maryland during the 1990s.Population-based surveillance study for meningococcal disease from January 1, 1990, through December 31, 1999, in Maryland.Maryland residents ...
L H, Harrison, M A, Pass, A B, Mendelsohn, M, Egri, N E, Rosenstein, A, Bustamante, J, Razeq, J C, Roche   +7 more
openaire   +2 more sources

Application of Causal Inference to Establish Assay Effect in the Absence of a Bridging Study: A Case Study of MenACWY‐CRM Conjugate Vaccine Data

Pharmaceutical Statistics, Volume 25, Issue 2, March/April 2026.
ABSTRACT During a vaccine development program, if the assay used to measure immunological endpoints is changed, ideally, a bridging study is performed to establish the relationship between results obtained with the new and previous assay. However, this is not always feasible, and when bridging study data are absent, this can limit the ability to use ...
Meike Adani, Silvia Noirjean, Andrea Callegaro, Pavitra Keshavan, Marco Costantini   +4 more
wiley   +1 more source

Meningocoxemic Septic Shock; A Case Report and Review of the Literature

Journal of Pediatric Emergency and Intensive Care Medicine, 2021
Meningococcal infections that have high mortality and morbidity in childhood and progress rapidly are an important health problem. It is one of the most important emergent diseases of the infectious diseases. Neisseria meningitidis has 13 serogroups.
Murat Özkale, Naime Gökay, Dinçer Yıldızdaş   +2 more
doaj   +1 more source

Neisseria meningitidis serogroup C sepsis and septic arthritis in an HIV-positive man [PDF]

, 2017
A patient with well-controlled HIV-1 infection presented with fever and rigors, a widespread maculopapular rash, and severe generalised arthralgia. Sepsis of unknown aetiology was diagnosed, and treatment with broad-spectrum antimicrobials commenced ...
Eades, CP, Fox-Lewis, A, Manson, JJ, Miller, RF, Morris-Jones, S   +4 more
core   +1 more source

Unusual Initial Abdominal Presentations of Invasive Meningococcal Disease [PDF]

Clinical Infectious Diseases, 2018
Invasive meningococcal disease (IMD) is recognized as septicemia and/or meningitis. However, early symptoms may vary and are frequently nonspecific. Early abdominal presentations have been increasingly described. We aimed to explore a large cohort of patients with initial abdominal presentations for association with particular meningococcal strains ...
Deghmane, Ala-Eddine, Guiddir, Tamazoust, Gros, Marion, Hong, Eva, Terrade, Aude, Denizon, Mélanie, Taha, Muhamed-Kheir   +6 more
openaire   +3 more sources

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source

Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease.

Value in Health, 2020
OBJECTIVES This cost-effectiveness analysis (CEA) of 4CMenB infant vaccination in England comprehensively considers the broad burden of serogroup B invasive meningococcal disease (MenB IMD), which has not been considered, or was only partially considered
E. Beck, J. Klint, M. Neine, S. Garcia, K. Meszaros   +4 more
semanticscholar   +1 more source

Invasive meningococcal disease presenting as Henoch-Sch�nlein purpura

European Journal of Clinical Microbiology & Infectious Diseases, 2004
Henoch-Schonlein purpura (HSP) is an acute systemic form of vasculitis that has been associated with a number of viral and bacterial infections. Described here are the cases of two children with invasive meningococcal disease who presented with clinical and laboratory findings typical of HSP.
Tsolia, MN, Fretzayas, A, Georgouli, H, Tzanakaki, G, Fessatou, S, Liapi-Adamidou, G, Constantopoulos, A   +6 more
openaire   +3 more sources

Meningococcal Serogroup Y Meningitis Reveals Inborn Factor B Deficiency

European Journal of Immunology, Volume 56, Issue 2, February 2026.
We report a novel case of complete complement Factor B deficiency revealed by invasive meningococcal disease. Using combined functional and genetic analyses, we demonstrate that loss of Factor B abolishes alternative pathway activity despite detectable protein levels. These findings provide a mechanistic framework relevant to complement diagnostics and
Camille Bougeard, Eléonore Eskander, Paula Vieira Martins, Joan Bitan, Julia Roquigny, Christèle Kyheng, Tamazoust Guiddir, Véronique Frémeaux‐Bacchi, Cécile Gonnin, Carine ElSissy   +9 more
wiley   +1 more source